drugset / Trial / NCT06035757
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
RandomizedParallel-groupDouble-blindPrevention
Summary
The present trial conducted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incidence of emergence agitation (EA) comparing to neostigmine
Timeline
- Start
- 2023-12-01
- Primary completion
- 2026-03-13
- Completion
- 2026-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pyridostigmine | Small molecule | 200 ug/kg | — |
| Comparator | Pyridostigmine | Small molecule | 350 ug/kg | — |
| Comparator | Sugammadex | Other / unclassified | 2 mg/kg | — |
| Comparator | Sugammadex | Other / unclassified | 4 mg/kg | — |